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The yeast-like fungus Cryptococcus neoformans favours respiration as a mechanism of energy
production, and thus depends heavily on mitochondrial function. Previous studies of a C.
neoformans vad1D mutant revealed reduced expression of the mitochondrial elongation factor
TUF1 and defects in glycerol utilization, consistent with mitochondrial dysfunction. In this study,
we found that in trans expression of TUF1 in the vad1D mutant suppressed the mitochondrial
defects, including growth on respiration-dependent carbon sources and fluconazole resistance,
associated with VAD1 deletion. Tetracycline, an inhibitor of mitochondrial translation, was found
to confer resistance to fluconazole in the wild-type and vad1D mutant, whereas the fluconazole
susceptibility of the TUF1-overexpressing strain was unaffected by tetracycline treatment. In the
presence of fluconazole, the vad1D mutant exhibited increased activation of the global
transcriptional regulator Sre1. TUF1 overexpression failed to alter cleavage of Sre1 in response to
fluconazole in the vad1D mutant, suggesting that TUF1 repression in the vad1D mutant is distal to
Sre1, or that it occurs through an independent pathway.
INTRODUCTION
Infections by the pathogenic fungus Cryptococcus neofor-
mans are occurring with increasing frequency in regions of
theworld plagued by theHIV epidemic,especiallyin regions
of Africa and South-East Asia, where C. neoformans has
become the most common cause of community-acquired
meningitis (Bicanic & Harrison, 2005). In addition, C.
neoformans represents a significant threat to transplant
recipients, as infections by C. neoformans can result in
allograft loss or even death (Husain et al., 2001; Singh et al.,
2005). The identification of novel therapeutic targets will aid
in the treatment and prevention of cryptococcosis in these
susceptible populations.
The basic mechanisms by which C. neoformans yeast cells
generate energy differ significantly from those of the model
yeast Saccharomyces cerevisiae. C. neoformans yeast cells rely
heavily on glycolysis and aerobic respiration for energy
production, with fermentation playing a minimal role
(Akhter et al., 2003). Both S. cerevisiae and C. neoformans
utilize the highly conserved cytochrome oxidase pathway
for electron transport. Three of the major constituents of
this pathway are encoded by the mitochondrial genome in
C. neoformans, and are translated using mitochondrial
translational machinery (Litter et al., 2005).
In addition to energy production, mitochondrial function
has been linked to antifungal resistance in the pathogenic
fungus Candida glabrata. Petite mutants of C. glabrata that
lack functional mitochondria are resistant to azole anti-
fungals (Brun et al., 2004). Fluconazole is an important
drug in anticryptococcal therapy, as it is the only azole
antifungal with adequate central nervous system penetra-
tion for treatment of cryptococcal meningoencephalitis
(Perfect & Durack, 1985). In addition, it is being used as
monotherapy in regions of Africa where lack of infrastruc-
ture precludes the use of amphotericin B (Bicanic et al.,
2006).
In C. neoformans, fluconazole sensitivity is regulated by the
sterol response element-binding protein Sre1 (Chang et al., Abbreviation: qRT-PCR, quantitative real-time PCR.
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neoformans, and is activated by the accumulation of 4-
methyl sterols (Hughes et al., 2007). A C. neoformans sre1D
mutant is severely attenuated in virulence, and exhibits
hypersensitivity to fluconazole (Chang et al., 2007; Chun et
al., 2007). A recent insertional mutagenesis study in C.
neoformans that utilized the hypoxia mimetic CoCl2 has
demonstrated that Sre1, mitochondrial function and sterol
metabolism are tightly linked (Ingavale et al., 2008).
We have previously described a mutant of C. neoformans
that lacks the DEAD-box RNA helicase Vad1; this mutant
was identified in an insertional mutagenesis screen for
genes involved in production of the virulence factor laccase
(Panepinto et al., 2005). The vad1D mutant exhibits a
moderate deficiency in melanization due to reduced
expression of laccase, but is severely attenuated in
virulence. Forward genetic screening revealed that the
vad1D mutant exhibited decreased expression of TUF1,a
nuclear gene encoding a homologue of EF-TU, which is an
elongation factor for translation within the mitochondrion
(Rosenthal & Bodley, 1987). Associated with downregula-
tion of TUF1 was impaired growth on medium containing
the respiration-dependent carbon source glycerol, suggest-
ing a defect in mitochondrial function in the vad1D mutant
(Panepinto et al., 2005).
In this study, we set out to determine whether over-
expression of TUF1 in the vad1D mutant was able to
suppress vad1D mitochondrial deficiency. We determined
that TUF1 overexpression could restore respiratory growth
and fluconazole sensitivity, and could suppress induction
of fluconazole resistance by tetracycline treatment.
However, hyperactivation of Sre1 in response to flucona-
zole treatment, and virulence defects of the vad1D mutant,
were unaffected by TUF1 overexpression. These data
suggest that downregulation of TUF1 contributes to the
mitochondrial defects of the vad1D mutant, and that the
influence of VAD1 deletion on activation of Sre1 is either
upstream of TUF1 influence or through an independent
pathway. These results also demonstrate that the flucona-
zole sensitivity of C. neoformans is dependent on
mitochondrial function, and they highlight the potential
for antibiotics that target bacterial protein synthesis to
antagonize the antifungal activity of fluconazole towards C.
neoformans.
METHODS
Construction of the v-K, v-TUF1 and wt-TUF1 strains. The
coding sequence of the TUF1 gene was amplified from genomic DNA
of C. neoformans wild-type strain H99 (J. Perfect, Duke University,
Durham, NC, USA) using primers TUFOE-F (59-GGAGGATG-
AATTCCATGCTCAGGAACGCCCTTCAGAG-39) and TUFOE-R
(59-GGAGGAGAATTCTCCCTTATTCGTAGATCTCTGAAACG-39)
for cloning in-frame with the actin promoter in pORA-KUTAP to
make pTUF1-KUTAP (Liu et al., 2006). Once verified by sequencing,
the expression construct and the empty vector were linearized with
Sce1, transformed into a previously described ura derivative of the
vad1D mutant, and selected on asparagine salts (ASN) agar
(Panepinto et al., 2005). Transformants were screened for episomal
maintenance of the constructs by uncut Southern blotting. One
vector control strain, v-K, and two TUF1-overexpression strains,
v-TUF1-1 and v-TUF1-2,w e r ec h o s e nf o rf u r t h e rs t u d y ,a n d
compared with a previously described wild-type strain harbouring
the pORA-KUTAP vector (Panepinto et al.,2 0 0 9 ) .S t r a i n sw e r e
maintained on ASN agar, unless otherwise indicated. As described
above, the pTUF1-KUTAP vector was introduced into a ura
derivative of the wild-type strain H99. Two strains were chosen for
further study, wt-TUF1-1 and wt-TUF1-5.
Spot-plate assay. Cells of each strain were grown on ASN agar for
2 days. A suspension of OD600 1.0 of each strain was made in sterile
deionized water. A 5 ml volume of this suspension, and five additional
1:5 dilutions, were spotted on ASN medium containing the indicated
carbon source. Plates were incubated at 37 uC for 4 days, and
photographed.
RNA isolation, Northern blot analysis and quantitative real-
time PCR (qRT-PCR). Cells of each strain were grown to mid-
exponential phase in yeast extract peptone dextrose (YPD) medium.
Cells were harvested by centrifugation, and RNA was extracted using
the Qiagen RNEasy mini kit, as described previously (Panepinto et al.,
2005). RNA was fractionated by formaldehyde agarose electrophoresis,
and transferred to a Hybond-N+ nylon membrane (GE Healthcare).
TUF1 and ACT1 expression was detected using
32P-labelled probes that
corresponded to the coding region of each gene. Hybridization was
visualized by autoradiography using Kodak BIOMax-XR film. qRT-
PCR for TUF1 expression was performed using intron-spanning
primers TUF1-qRT-F (59-CACTGCCCATGTTGAATACG-39) and
TUF1-qRT-R (59-CATATTTTTGATGTAATCGGC-39), which corre-
spond to an 85 bp region of the TUF1 cDNA, and ACT1-qRT-F (59-
CTCTATGAAGTGTGATCTCG-39) and ACT1-qRT-R (59-CATA-
CGGTCGGCAATACC-39), which amplify a 100 bp region of the
ACT1 reference gene cDNA. Reverse transcription was performed on
DNase-treated RNA using the iScript kit (Bio-Rad Laboratories),
according to the manufacturer’s protocol. PCRs were set up using iQ
SyberGreen SuperMix (Bio-Rad Laboratories), according to the
manufacturer’s protocol. Briefly, a master mix was prepared to allow
each reaction to contain 12.5 ml SyberGreen SuperMix, 10.5 ml diethyl-
pyrocarbonate-treated water, 0.5 ml forward primer and 0.5 ml reverse
primer. A 1 ml volume of cDNA was added to each reaction. qRT-PCR
was performed using either a Bio-Rad iCycler or an iQ Real-Time PCR
system. TUF1 expression was calculated using the comparative Ct
method, and normalized against ACT1 expression (Livak &
Schmittgen, 2001).
MIC determination. Fluconazole MICs were determined using broth
microdilution and Etest (AB Biodisk). The broth microdilution assay
was performed as recommended by the Clinical and Laboratory
Standards Institute (CLSI), with the following modification: assays
were performed in RPMI medium containing 2% glucose, and
buffered to pH 7 with 10 mM MOPS (Petrou & Shanson, 2000). The
first non-turbid well was read as the MIC. Etests were carried out as
described by the manufacturer, and were performed on SD agar [16
yeast nitrogen base (YNB) without amino acids, 2% glucose].
Sterol scan analysis. Sterol levels were measured as described by
Arthington-Skaggs et al. (1999), with the following alterations. Strains
were inoculated at a density of OD600 0.2 in 30 ml SD medium from
an overnight starter culture. Cells were grown in a shaking incubator
at 30 uC and 250 r.p.m. for 72 h. The OD600 of the cultures was
measured, and approximately 80 OD units of cells [the concentration
of cells (as OD units per ml) multiplied by the culture volume in ml]
was subjected to heptane extraction. Extracted sterols were diluted
1:1 with ethanol and scanned spectrophotometrically from 230
to 300 nm on a SpectraMax M5 plate reader/spectrophotometer
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Western blot analysis. Cells of the wt-K, v-K and v-TUF1-1 strains
were grown to mid-exponential phase in YPD broth. Following the
addition of 4 mg fluconazole ml
21, cells were harvested at 0, 2 and
4 h. Total protein was extracted by mechanical disruption for 5 min,
alternating vortexing and chilling every 30 s. The lysates were cleared
by centrifugation at 15000 g for 5 min, after which proteins were
quantified using the Bio-Rad Protein Assay reagent. A 15 mg quantity
of total protein from each time point was run on a 4–12% SDS-PAGE
gel and transferred to a nitrocellulose membrane. Full-length and
cleaved Sre1 was detected using polyclonal antiserum against Sre1
(1:250; a generous gift from Peter Espenshade, Johns Hopkins
University School of Medicine, Baltimore, MD, USA), and a
peroxidase-conjugated anti-rabbit secondary antibody (1:1000;
Pierce). Antibody reactivity was visualized using Super Signal West
Pico reagent, as recommended by the manufacturer (Pierce).
Virulence studies. wt-K, v-K and v-TUF1 strains were inoculated
into the lateral tail vein of Swiss albino mice (National Institutes of
Health), using 1610
6 cells for each inoculation. A total of 10 mice
were inoculated per group, and mouse health was monitored over
50 days. Moribund mice were sacrificed by CO2 narcosis. All animal
studies were performed in accordance with the University of Illinois
at Chicago Institutional Animal Care and Use Committee regulations.
Melanization was assayed on ASN agar without glucose, pH 6.5, and
with 50 mgm l
21 L-3,4-dihydroxyphenylalanine (L-DOPA) as a laccase
substrate. The degree of melanization was observed after 24 h at
30 uC.
RESULTS AND DISCUSSION
Overexpression of TUF1 suppresses vad1D
respiratory growth defects
Our previous studies have demonstrated that the C.
neoformans vad1D mutant exhibits reduced expression of
the mitochondrial translation elongation factor TUF1, and
that it is defective in utilization of respiration-dependent
carbon sources (Panepinto et al., 2005). In addition,
knockout of TUF1 in wild-type C. neoformans by RNA
interference completely inhibits growth on glycerol, leading
us to hypothesize that the respiratory defects exhibited by
the vad1D mutant are due to TUF1 downregulation
(Panepinto et al., 2005). To further test this hypothesis,
we constructed v-TUF1, which was a C. neoformans Dvad1
strain harbouring an episomal vector expressing TUF1
under the control of the ACT1 promoter in pORA-
KUTAP. For the following studies, v-TUF1 was compared
with a wild-type strain (wt-K) described previously
(Panepinto et al., 2009) and a vad1D strain (v-K),
harbouring the empty vector (this study). The level of
TUF1 overexpression achieved by introduction of the
episomal construct was measured by Northern blotting
(Fig. 1a). Independent assessment of TUF1 overexpression
in these strains by qRT-PCR revealed that TUF1 was
overexpressed 3.5- and 4.0-fold in v-TUF1-1 and v-TUF1-
2, respectively, relative to v-K, when normalized to the
ACT1 reference gene. To determine whether overexpres-
sion of TUF1 could restore growth on respiration-
dependent carbon sources, we compared the growth of v-
TUF1-1 and v-TUF1-2 with that of wt-K and v-Ko n
glycerol, pyruvate and lactate in a spot-plate assay. As
demonstrated in Fig. 1(b), overexpression of TUF1
restored growth of the vad1D strain on respiration-
dependent carbon sources. This is consistent with data
from S. cerevisiae, in which overexpression of TUF1 is able
to suppress respiratory defects of mitochondrial tRNA
mutants (De Luca et al., 2006). These data suggest that the
respiratory defects of the vad1D mutant are linked to
repression of TUF1 expression.
To determine the effect of TUF1 overexpression on carbon
source utilization in wild-type C. neoformans, we compared
the growth of two independent isolates of wild-type
Fig. 1. (a) Northern blot analysis of TUF1 expression in wt-K, v-K
and v-TUF1 strains. RNA was harvested from cultures grown to
mid-exponential phase in YPD broth at 30 6C. RNA was hybridized
with TUF1 and ACT1 probes. (b) Spot-plate assay demonstrating
restoration of growth on respiration-dependent carbon sources by
overexpression of TUF1 in the vad1D mutant. Plates contained the
indicated carbon sources at 2% in ASN agar, pH 6.5. Plates were
incubated at 37 6C for 4 days and then photographed.
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struct with that of the vector control strain, as described
above, by spot-plate assay. Both wt-TUF1 strains exhibited
a severe growth defect on minimal medium with glucose as
the carbon source (Fig. 2a). Surprisingly, the growth of
both wt-TUF1 strains appeared more robust in medium
with glycerol as the carbon source compared with growth
in medium containing glucose, with overall growth still less
than that of the wt-K strain (Fig. 2b). The level of TUF1
overexpression as measured by qRT-PCR was found to be
1.5-fold for wt-TUF1-1 and 1.6-fold for wt-TUF1-5,
relative to wt-K, at 30 uC in YPD medium using ACT1
expression for normalization. These results suggest that
although TUF1 overexpression is able to compensate for
mitochondrial defects in a vad1D mutant, even modest
inappropriate overexpression of TUF1 in wild-type C.
neoformans has detrimental effects on growth, especially at
37 uC in the presence of glucose.
Overexpression of TUF1 suppresses fluconazole
resistance in the vad1D mutant
A recent study has demonstrated that inhibition of
mitochondrial protein synthesis with tetracycline induces
fluconazole resistance in Candida albicans and C. neofor-
mans, with the effect on C. neoformans being much greater
than on Candida albicans (Oliver et al., 2008). This led us
to hypothesize that downregulation of TUF1 in the vad1D
mutant could confer fluconazole resistance that would be
suppressed by TUF1 overexpression. To test this hypo-
thesis, the fluconazole sensitivity of wt-K, v-K, v-TUF1-1
and v-TUF1-2 was assessed by Etest. As demonstrated in
Fig. 3, comparison of fluconazole MICs by the Etest
method revealed an increase in MIC in v-K compared with
the wt-K strain, with the v-TUF1-1 and v-TUF1-2 strains
exhibiting decreased fluconazole MICs compared with the
parent v-K strain. The fluconazole MIC was also measured
by broth microdilution, and the MICs for the v-K and wt-K
strains were found to be 8 and 2 mgm l
21, respectively, in
each of three replicate assays, demonstrating further that
VAD1 deletion results in fluconazole resistance. The
fluconazole MICs of the v-TUF1-1 and v-TUF1-2 strains,
as measured by broth microdilution, were equivalent to
that of the wt-K strain, with each strain exhibiting a MIC
value of 2 mgm l
21 in three replicate experiments. This is
consistent with the ability of TUF1 overexpression to
suppress the fluconazole resistance of the vad1D mutant.
Disparities in the MIC results between the two methods are
likely to stem from differences in growth medium.
However, both assays demonstrate that the v-K strain
exhibits resistance to fluconazole relative to wt-K, and that
overexpression of TUF1 restores fluconazole sensitivity to
the vad1D mutant. These data demonstrate that over-
expression of TUF1 in the vad1D mutant is able to suppress
the fluconazole-resistant phenotype. Because the effect of
TUF1 overexpression in vad1D had the same consequences
in both v-TUF1-1 and v-TUF1-2, only v-TUF1-1 was
assayed in the following studies.
TUF1 overexpression abrogates tetracycline-
induced fluconazole resistance
Tetracycline is thought to affect mitochondrial function
through inhibition of mitochondrial translation, similar to
the expected consequence of TUF1 downregulation (Zhang
et al., 2005). If TUF1 overexpression restores fluconazole
sensitivity through upregulation of mitochondrial trans-
lation, we would expect the v-TUF1-1 strain to be
insensitive to tetracycline-induced fluconazole resistance.
To test this hypothesis, we determined fluconazole MICs
by Etest analysis on wt-K, v-K and v-TUF1-1 in the
presence of increasing concentrations of tetracycline (Fig.
4). As previously reported for wild-type C. neoformans,
tetracycline increased the fluconazole MIC of both wt-K
and v-K (Oliver et al., 2008). However, tetracycline had
little effect on the fluconazole MIC of v-TUF1-1,e v e na t
400 mg tetracycline ml
21. This suggests that overexpression
of TUF1 renders mitochondrial translation less sensitive to
inhibition by tetracycline. In addition, it confirms that the
effect of tetracycline on fluconazole sensitivity is a result of
its activity as an inhibitor of mitochondrial translation.
The mechanism by which mitochondrial translation can
influence fluconazole sensitivity is unknown. Studies in
Candida albicans demonstrate only a modest increase in
fluconazole MIC in the presence of tetracycline relative to
the drastic effect seen in C. neoformans (Oliver et al., 2008).
Likewise, sterol profiles of Candida albicans in the presence
of tetracycline show only a modest difference from
untreated controls. To determine whether sterol content
was affected by tetracycline treatment, sterols were
extracted from wt-K, v-K and v-TUF1-1 grown in the
presence and absence of 200 mg tetracycline ml
21, and a
sterol profile was obtained for each strain. As demonstrated
Fig. 2. Overexpression of TUF1 in wild-type C. neoformans is
growth-inhibitory. Growth of two independently derived TUF1-
overexpression strains was compared with that of a wild-type
strain harbouring the empty vector (wt-K) by spot-plate assay at
37 6C on minimal medium containing either glucose (a) or glycerol
(b) as the carbon source.
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increased fluconazole MIC in the v-K strain
compared with the wild-type control (wt-K).
Fluconazole sensitivity was restored by over-
expression of TUF1 (v-TUF1-1 and v-TUF1-2).
Fig. 4. Etest analysis showing fluconazole
MICs in the presence of tetracycline (TET) at
50 and 400 mgm l
”1 in wt-k, v-K and v-TUF1-1
strains. Etests were performed on SD agar,
with and without the indicated concentration of
tetracycline, incubated at 30 6C for 3 days,
and then photographed.
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(±SEM) for each strain correlated with the fluconazole
MIC, with the v-K strain exhibiting the highest-profile
peaks and fluconazole resistance, and the v-TUF1 strain the
lowest-profile peaks and fluconazole sensitivity. wt-K was
intermediate in profile peaks and fluconazole MIC.
Treatment with 200 mg tetracycline ml
21 was found to
increase peak height in all three strains (Fig. 5), with the
effect being most significant in the wt-K strain. It should
be noted, however, that the increase in peak height in
the tetracycline-treated v-TUF1-1 strain did not reach the
height of the untreated wt-K profile, consistent with the
lack of tetracycline-induced fluconazole resistance observed
in the v-TUF1-1 strain. The magnitude of the profiles in
tetracycline-treated wt-K and v-K was similar, and this
might suggest that these strains were approaching a
maximum in sterol synthesis. In addition, we would expect
the effect of tetracycline on the v-K strain to be less, as
overall mitochondrial translation is likely to be reduced
owing to TUF1 repression, resulting in an increased sterol
profile height in the absence of tetracycline. Taken
together, these data suggest that TUF1 repression, or
inhibition of mitochondrial translation with tetracycline,
confers fluconazole resistance, at least in part, through an
increase in sterol content. Future studies will investigate the
mechanism by which sterol content is upregulated in these
strains. A possible explanation for the differences in
tetracycline-induced fluconazole resistance between
C. neoformans and Candida albicans may stem from
fundamental metabolic differences between these two
pathogenic fungi. Consistent with this interpretation is
that TUF1 appears to be an essential gene, since our
previously described attempts to generate a deletion
mutant were unsuccessful (Panepinto et al., 2005). In
contrast, the S. cerevisiae TUF1 orthologue is not essential,
with the deletion mutant exhibiting respiratory growth
defects (Chiron et al., 2005). The pronounced effects of
tetracycline on C. neoformans fluconazole susceptibility
observed previously, and the essential nature of TUF1 in C.
neoformans, are consistent with the minimal fermentative
capacity of C. neoformans compared with the ascomycetous
yeast. The reduced capacity of C. neoformans to ferment is
likely to result in strong reliance on mitochondrial
function, whereas Candida albicans and S. cerevisiae favour
fermentative pathways to produce ATP.
The vad1D mutant hyperactivates Sre1 in
response to fluconazole
The response of C. neoformans to azole antifungal drugs
includes activation of Sre1 (Chang et al., 2007; Chun et al.,
2007). Sre1 responds to the accumulation of 4-methyl
sterols that occurs during antifungal drug treatment and
hypoxia, and deletion of SRE1 confers profound flucona-
zole sensitivity (Chang et al., 2007; Hughes et al., 2007).
Microarray experiments have demonstrated that the
hypoxic response in C. neoformans involves downregula-
tion of TUF1, similar to that seen in the vad1D mutant
(Chun et al., 2007). These similarities in gene expression,
coupled with fluconazole resistance and increased sterol
content, led us to hypothesize that the vad1D mutant
would hyperactivate Sre1 in response to fluconazole
treatment. As demonstrated in Fig. 6(a), the vad1D mutant
exhibited increased activation of Sre1 after fluconazole
treatment for 2 h, whereas wild-type Sre1 activation was
barely visible after drug treatment for 2 h. However,
overexpression of TUF1 in the vad1D mutant had no effect
on the hyperactivation of Sre1 (Fig. 6b), suggesting that
Fig. 5. (a) UV scans of heptane-extracted sterols from cultures grown in the presence and absence of tetracycline. Data shown
are representative of three independent assays; vertical bars, SEM. TET, tetracycline.
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that it functions in an independent pathway. This is also
supported by the inability of tetracycline to increase
resistance to fluconazole in the sre1D mutant (Fig. 6c).
Taken together, these data support a model in which TUF1
downregulation in a vad1D mutant may be a direct result
of Sre1 dysregulation. Future studies will test this model,
and investigate a regulatory role of Vad1 in Sre1 activation.
Overexpression of TUF1 in the vad1D mutant does
not restore virulence
Our previous studies have demonstrated that severe
virulence attenuation accompanies deletion of VAD1
(Panepinto et al., 2005). To determine the contribution
of TUF1 downregulation to vad1D virulence attenuation,
the ability of a TUF1-expressing vad1D strain to cause
mortality in a murine model of cryptococcosis was
compared with that of the wild-type and vad1D mutant
derivatives bearing an empty vector. Cells (1610
6) of each
strain were injected into the lateral tail vein of Swiss albino
mice, and mortality was monitored for 7 weeks. All of the
wild-type mice succumbed to infection in the first 2 weeks,
whereas none of the mice infected with the vad1D mutant
succumbed to the infection. One mouse infected with the
TUF1-expressing strain succumbed to infection on day 21,
with the remaining nine mice surviving to 7 weeks, at
which time the experiment was terminated (data not
shown). This suggests that restoration of TUF1 expression
in the vad1D mutant is not sufficient to restore virulence,
and that the virulence defects of the vad1D mutant are
most likely due to effects on multiple genes, as Vad1 is a
global regulator.
Because VAD1 was initially discovered in a screen for C.
neoformans mutants defective in melanization, we assayed
the effect of TUF1 overexpression on the melanin
deficiency of the vad1D mutant. Overexpression of TUF1
did not restore wild-type melanization to the vad1D mutant
(data not shown), consistent with the inability of TUF1
overexpression to restore virulence traits to the vad1D
mutant.
In this study, we demonstrated that overexpression of
TUF1, encoding the mitochondrial translation elongation
factor, was able to suppress several aspects of the vad1D
phenotype related to mitochondrial function. These aspects
included rescuing growth on respiration-dependent carbon
sources and restoring fluconazole sensitivity. This study
supports a role for mitochondrial protein synthesis in the
regulation of fluconazole sensitivity, demonstrating that
inhibition of mitochondrial protein synthesis by tetracy-
cline confers resistance to fluconazole in C. neoformans and
increases overall sterol content. These results not only
provide insight into possible mechanisms of drug resist-
ance in C. neoformans, but also highlight potential
interactions of antimicrobial agents in patients undergoing
treatment for polymicrobial infections. This study raises
the possibility that antibacterial agents that target protein
synthesis antagonize the activity of azole antifungal drugs.
Future studies using animal models of cryptococcal
infection will address this question in vivo.
The study also points to the unique reliance of C.
neoformans on mitochondrial respiration. Perturbation of
Fig. 6. Western blot analysis of Sre1 activation in response to
fluconazole treatment. (a) Time course of Sre1 activation in the
presence of 4 mgm l
”1 fluconazole (FC) comparing the wt-K and v-
K strains. Activation of Sre1 is indicated by the appearance of the
cleavage fragment (CL) in addition to the inactive, full-length Sre1
band (FL). (b) Time course of Sre1 activation in the presence of
4 mg fluconazole ml
”1, comparing the v-K and TUF1-K strains. (c)
Etests comparing the fluconazole sensitivity of wild-type strain
H99 (wt) with that of a sre1D mutant in the presence and absence
of 200 mgm l
”1 tetracycline (TET).
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vad1D mutant, affects carbon metabolism, sterol metabol-
ism and susceptibility to fluconazole. Similar effects on
sterol metabolism and fluconazole sensitivity were recapi-
tulated by treatment with tetracycline. In addition, over-
expression of TUF1 in wild-type C. neoformans appears to
impair glucose utilization, favouring the use of respiration-
dependent glycerol under the conditions tested herein.
Further studies of mitochondrial function in this import-
ant pathogen could identify targets for antifungal therapy
that may confer fluconazole sensitivity by activating, rather
than impairing, aspects of mitochondrial function.
Although overexpression of TUF1 was able to act as a
phenotypic suppressor of vad1D mitochondrial defects, it
was unable to restore virulence to the vad1D mutant.
Therefore, the regulatory defects underlying the complex
phenotype of the vad1D mutant likely arise from
modulation of multiple targets, as Vad1 is a regulator of
many genes and pathways. The mechanism by which TUF1
is downregulated in the vad1D mutant is unclear, and a
possibility that TUF1 repression is secondary to defects in
another regulator, such as Sre1, remains. Further studies
delineating the role of Vad1 as a regulator of mRNA fate
will determine the specific target transcripts regulated by
Vad1, and lead to a mechanistic understanding of the
vad1D phenotype.
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